XML 60 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
CURRENT ASSETS:    
Cash and cash equivalents $ 1,041,280 $ 526,597
Restricted cash and cash equivalents 67,505 770,000
Marketable securities 74,279 0
Accounts receivable 790,508 725,827
Inventories, net 464,099 374,439
Prepaid expenses and other current assets 87,822 39,402
Income taxes receivable 47,126 0
Deferred income taxes 217,572 257,985
Assets held for sale (NOTE 3) 0 160,257
Total current assets 2,790,191 2,854,507
MARKETABLE SECURITIES 2,396 2,979
PROPERTY, PLANT AND EQUIPMENT, NET 381,452 372,077
GOODWILL 3,522,651 1,372,832
OTHER INTANGIBLES, NET 2,662,676 1,872,926
OTHER ASSETS 168,603 96,535
TOTAL ASSETS 9,527,969 6,571,856
CURRENT LIABILITIES:    
Accounts payable 298,099 263,241
Accrued expenses 1,323,839 979,964
Current portion of long-term debt 402,245 414,929
Acquisition-related contingent consideration 3,877 3,878
Income taxes payable 0 3,089
Liabilities related to assets held for sale (NOTE 3) 0 31,571
Total current liabilities 2,028,060 1,696,672
DEFERRED INCOME TAXES 250,872 310,764
ACQUISITION-RELATED CONTINGENT CONSIDERATION 882 869
LONG-TERM DEBT, LESS CURRENT PORTION, NET 3,495,646 3,323,844
OTHER LIABILITIES 715,146 654,491
COMMITMENTS AND CONTINGENCIES (NOTE 12)      
SHAREHOLDERS’ EQUITY:    
Euro deferred shares, €0.01 par value; 4,000,000 shares authorized; 4,000,000 issued 55 0
Ordinary shares, $0.0001 and $0.01 par value; 1,000,000,000 and 350,000,000 shares authorized; 152,205,074 and 144,413,074 shares issued; 152,205,074 and 115,354,393 shares outstanding at March 31, 2014 and December 31, 2013, respectively 15 1,444
Additional paid-in capital 3,278,121 1,166,375
Retained (deficit) earnings (310,678) 126,234
Accumulated other comprehensive loss (178) (4,915)
Treasury stock, zero and 29,058,681 shares at March 31, 2014 and December 31, 2013, respectively 0 (763,120)
Total Endo Health Solutions Inc. stockholders’ equity 2,967,335 526,018
Noncontrolling interests (NOTE 3) 70,028 59,198
Total stockholders’ equity 3,037,363 585,216
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 9,527,969 $ 6,571,856